CURE

FDA Approves Akeega Combo in BRCA2+ Metastatic Prostate Cancer

The FDA approved Akeega combination therapy for adults with BRCA2-mutated metastatic castration-sensitive prostate cancer.
CURE

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...
CURE

Electronic Intervention Improves Quality of Life in Younger Breast Cancer Survivors

The YES intervention improved general and cancer-specific quality of life in AYA breast cancer survivors over six months.
CURE

Suleika Jaouad, Reporting From the Front Lines of Leukemia

For 15 years, Suleika Jaouad has reported from the front lines of cancer treatment. Jaouad, the Emmy-winning journalist and ...
CUREOpinion

Knowledge Isn’t Enough When Action Costs Too Much

Rising healthcare costs and changing coverage increase financial burdens for individuals with hereditary conditions like ...
CURE

What Does Minimal Residual Disease Mean?

During the 2025 American Society of Hematology annual meeting, held earlier this month in Orlando, Florida, CURE sat down ...
CURE

FDA Grants Priority Review for Opdivo Combo in Advanced Lymphoma

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma, by Bristol ...
CURE

Acupuncture Improves Cognitive Function in Breast Cancer Survivors

Real and sham acupuncture were both linked to clinically meaningful and lasting improvements in perceived cognitive impairment compared with usual care for breast cancer survivors, but real ...